Key result
Intermittent blood-flow restriction pre-activation increases jump height by ~0.14 m vs a continuous protocol.
Why the study?
To investigate the acute effects of continuous versus intermittent blood-flow restriction combined with countermovement jump exercise on post-activation potentiation, clarify time-course characteristics, and identify the optimal potentiation window.
Does an intermittent blood-flow restriction protocol improve post-activation potentiation compared to a continuous protocol in healthy male track-and-field athletes?
RCT (n=18)
randomized, crossover
Does an intermittent blood-flow restriction protocol improve post-activation potentiation compared to a continuous protocol in healthy male track-and-field athletes?
Intermittent blood-flow restriction during pre-activation exercises enhances explosive power and jump height, with an optimal window within 8 minutes post-stimulus, whereas continuous restriction impairs performance.
Objectives To investigate the acute effects of two pre-activation protocols combining blood-flow restriction (BFR) with acute countermovement jump (CMJ) exercise on post-activation potentiation (PAP), to clarify their time-course characteristics and identify the optimal potentiation window, and to elucidate the underlying physiological mechanisms regarding the balance between neuromuscular potentiation and metabolic fatigue induced by different occlusion patterns. Materials and methods Eighteen healthy male track-and-field athletes specializing in sprint and jump events participated in this study, which utilized a randomized, crossover, repeated-measures design. Kinetic data were collected using a Kistler 3D force plate at baseline and at 0, 4, 8, 12, and 16 min post-stimulus following two distinct protocols executed at 50% arterial occlusion pressure: (1) a continuous protocol, involving one set of five CMJs with BFR maintained during 60-s rest intervals; and (2) an intermittent protocol, involving one set of five CMJs with BFR released during rest intervals. The PAP effect was evaluated based on jump height, peak power, peak vertical ground reaction force (vGRF), and the average rate of force development (RFD). Results Two-way repeated-measures ANOVA revealed significant protocol × time interaction effects for all kinetic variables ( P = 0.001; η p 2 = 0.73–0.81). Compared to the continuous protocol, the intermittent protocol yielded a significantly higher main effect for jump height (mean difference: 0.14 m, 95% CI: 0.13 to 0.16 m; P = 0.001; η p 2 = 0.79) and peak power (mean difference: 12.68 W·kg −1 , 95% CI: 12.16 to 13.08 W·kg −1 ; P = 0.001; η p 2 = 0.76). In the continuous protocol, all kinetic parameters across the 0 to 16-min time points were significantly reduced relative to baseline ( P < 0.05; η p 2 = 0.72–0.75), demonstrating immediate and sustained performance inhibition. Conversely, jump height, peak power, peak VGRF, and average RFD in the intermittent protocol were significantly increased at 0, 4, and 8 min compared to baseline values ( P < 0.05; η p 2 = 0.65–0.77), with peak enhancements manifesting between 4 and 8 min before returning to baseline at 12 min ( P < 0.05). Conclusion The results indicate that the acute intermittent BFR pre-activation protocol successfully induces post-activation potentiation, effectively enhancing CMJ height and explosive power. Conversely, the continuous protocol fails to elicit PAP and instead exerts an acute inhibitory effect due to prolonged occlusion and accumulated fatigue. The optimal temporal window to exploit the PAP effect induced by the intermittent protocol is within 8 min post-stimulus.
No takes yet. Share an insight, caveat, or question.
Yao et al. (2026) conducted an RCT in Healthy male track-and-field athletes (n=18). Intermittent blood-flow restriction (BFR) with acute countermovement jump (CMJ) vs. Continuous BFR protocol was evaluated on Jump height (MD 0.14 m, 95% CI 0.13 to 0.16, p=0.001). An intermittent blood-flow restriction pre-activation protocol significantly increased jump height compared to a continuous protocol (mean difference 0.14 m; 95% CI 0.13-0.16; P=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: